NPC1 and epilepsy: Thus, our isogenic TSC1 NPC cell models provide an opportunity to screen for drugs that could reverse the early neurodevelopmental phenotypes such as NPC proliferation and neurite outgrowth, which may ultimately lead to better treatment for TSC-associated epilepsy and neuropsychiatric defects.